American Heart Journal
Volume 156, Issue 4 , Pages 656-661 , October 2008

Efficacy of LOw-dose DObutamine Stress-Echocardiography to predict Cardiac Resynchronization Therapy Response (LODO-CRT) multicenter prospective study—Design and rationale

  • Carmine Muto, MD

      Affiliations

    • Ospedale Santa Maria di Loreto Mare, Napoli, Italy
    • ,
  • Maurizio Gasparini, MD

      Affiliations

    • IRCCS Istituto Clinico Humanitas, Rozzano (Milano), Italy
    • Corresponding Author InformationReprint requests: Maurizio Gasparini, MD, Electrophysiology and Pacing Unit, IRCCS Istituto Clinico Humanitas, Via Manzoni 56, 20089 Rozzano (MI), Italy.
    • ,
  • Saverio Iacopino, MD

      Affiliations

    • Sant'Anna Hospital, Catanzaro, Italy
    • ,
  • Carlo Peraldo, MD

      Affiliations

    • Ospedale Fatebenefratelli - San Giovanni Calibita, Roma, Italy
    • ,
  • Antonio Curnis, MD

      Affiliations

    • Spedali Civili, Brescia, Italy
    • ,
  • Biagio Sassone, MD

      Affiliations

    • Ospedale Consorziale, Bentivoglio (Bologna), Italy
    • ,
  • Paolo Diotallevi, MD

      Affiliations

    • Ospedale Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
    • ,
  • Mario Davinelli, PhD

      Affiliations

    • Clinical Department, Medtronic Italia, Roma, Italy
    • ,
  • Sergio Valsecchi, PhD

      Affiliations

    • Clinical Department, Medtronic Italia, Roma, Italy
    • ,
  • Bernardino Tuccillo, MD

      Affiliations

    • Ospedale Santa Maria di Loreto Mare, Napoli, Italy

Received 29 January 2008 ,Accepted 9 June 2008.

References 

  1. Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002;39:2026–2033
  2. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intra-ventricular conduction delay. N Engl J Med. 2001;344:873–880
  3. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–1853
  4. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA. 2003;289:2685–2694
  5. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150
  6. Auricchio A, Stellbrink C, Butter C, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol. 2003;42:2109–2116
  7. Bax JJ, Van der Wall EE, Schalij MJ. Cardiac resynchronization therapy for heart failure. N Engl J Med. 2002;347:1803–1804
  8. Cleland J, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–1549
  9. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation. 2005;112:1116–1143
  10. Vardas PE, Auricchio A, Blanc JJ, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J. 2007;28:2256–2295
  11. Yu CM, Fung JW, Chan CK, et al. Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure. J Cardiovasc Electrophysiol. 2004;15:1058–1065
  12. Gasparini M, Auricchio A, Regoli F, et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol. 2006;48:734–743
  13. Birnie DH, Tang ASL. The problem of non-response to cardiac resynchronization therapy. Curr Opin Cardiol. 2006;21:20–26
  14. Gasparini M, Mantica M, Galimberti P, et al. Is the outcome of cardiac resynchronization therapy related to the underlying etiology?. Pacing Clin Electrophysiol. 2003;26:175–180
  15. Gasparini M, Mantica M, Galimberti P, et al. Is the left ventricular lateral wall the best lead implantation site for cardiac resynchronization therapy?. Pacing Clin Electrophysiol. 2003;26:162–168
  16. Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol. 2002;40:1615–1622
  17. Yu CM, Zhang O, Fung JW, et al. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol. 2005;45:677–684
  18. Bax JJ, Bleeker GB, Marwick TH, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1834–1840
  19. Marcus GM, Rose E, Viloria EM, et al. Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol. 2005;46:2208–2214
  20. Chung ES, Leon AR, Tavazzi L, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117:2608–2616
  21. Cigarroa CG, De Filippi CR, Brickner ME, et al. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation. 1993;88:430–436
  22. La Canna G, Alfieri O, Giubbibi R, et al. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:617–626
  23. Marmor A, Scneeweiss A. Prognostic value of noninvasively obtained left ventricular contractile reserve in patients with severe heart failure. J Am Coll Cardiol. 1997;29:422–428
  24. Pinamonti B, Perkan A, Di Lenarda A, et al. Dobutamine echocardiography in idiopathic dilated cardiomyopathy: clinical and prognostic implications. Eur J Heart Fail. 2002;4:49–61
  25. Seghatol FF, Shah DJ, Diluzio S, et al. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2004;93:854–859
  26. Da Costa A, Thevenin J, Roche F, et al. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders. Heart Rhythm. 2006;3:406–413
  27. Cleland JG, Daubert JC, Erdmann E, et al. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail. 2001;3:481–489
  28. Penicka M, Bartunek J, De Bruyne B, et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation. 2004;109:978–983
  29. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail. 2001;7:176–182
  30. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantization of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantization of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–367
  31. Agricola E, Oppizzi M, Pisani M, Margonato A. Stress echocardiography in heart failure. Cardiovasc Ultrasound. 2004;2:11
  32. Yu CM, Bleeker GB, Fung JWH, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation. 2005;112:1580–1586
  33. Tuccillo B, Muto C, Ascione L, et al. Usefulness of left ventricular contractile reserve by dobutamine stress echocardiography as an effective tool to predict response to cardiac resynchronization therapy. Heart Rhythm. 2006;3(1S):S25
  34. Hawkins NM, Petrie MC, MacDonald MR, et al. Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?. Eur Heart J. 2006;27:1270–1281
  35. White JA, Yee R, Yuan X, et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intra-ventricular dyssynchrony. J Am Coll Cardiol. 2006;48:1953–1960
  36. Ypenburg C, Roes SD, Bleeker GB, et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol. 2007;99:657–660

PII: S0002-8703(08)00478-X

doi: 10.1016/j.ahj.2008.06.011

American Heart Journal
Volume 156, Issue 4 , Pages 656-661 , October 2008

Article Tools

* Image Usage & Resolution